Filing Flows › Elevance Health (ELV) › Q3 2026 › vs Q3 2025
Elevance Health (ELV) Q3 2026 vs Q3 2025 (year over year)
Elevance Health's revenue rose $718M (+1%) from $50.7B in Q3 2025 to $51.4B in Q3 2026. Operating margin 2.5% against 2.6% (-0.1 pts).
Elevance Health, Q3 2026: revenue $51.4B (+1% year over year), operating margin 2.5%, net earnings $1.3B, operating cash flow $1.3B. The chart draws each line against Q3 2025, the increases inside each band.
Margins
| Q3 2026 | Q3 2025 | Change | |
|---|---|---|---|
| Operating margin | 2.5% | 2.6% | -0.1 pts |
| Net margin | 2.6% | 2.3% | +0.3 pts |
| Free cash flow margin | 1.9% | 1.5% | +0.4 pts |
Every line
| Line | Q3 2026 | Q3 2025 | Change | % |
|---|---|---|---|---|
| Revenue | $51.4B | $50.7B | $718M | +1% |
| Other income, net | $525M | $111M | $414M | +373% |
| Operating profit | $1.3B | $1.3B | −$26.0M | -2% |
| Costs & expenses | $50.2B | $49.4B | $744M | +2% |
| Pre-tax earnings | $1.8B | $1.4B | $388M | +28% |
| Cost of revenue | $5.6B | $5.4B | $260M | +5% |
| SG&A | $5.8B | $5.3B | $480M | +9% |
| Other operating costs | $38.8B | $38.8B | $4.0M | 0% |
| Net earnings | $1.3B | $1.2B | $156M | +13% |
| Income tax | $451M | $219M | $232M | +106% |
| Depreciation & amortization | $363M | $387M | −$24.0M | -6% |
| Share-based compensation | $80.0M | $84.0M | −$4.0M | -5% |
| Working capital & other | $519M | $523M | −$4.0M | -0.8% |
| Operating cash flow | $1.3B | $1.1B | $132M | +12% |
| Free cash flow (OCF − capex) | $1.0B | $775M | $225M | +29% |
| Capital expenditures | $267M | $360M | −$93.0M | -26% |
Questions
How much did Elevance Health's revenue grow year over year in Q3 2026?
Elevance Health's revenue rose $718M (+1%) from $50.7B in Q3 2025 to $51.4B in Q3 2026. Operating margin 2.5% against 2.6% (-0.1 pts).